The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Evidence-based management of patients with nonalcoholic fatty liver disease
JAAPA. 2022 Aug 1;35(8):20-24. doi: 10.1097/01.JAA.0000840492.53680.59.
1Minal Patel practices in gastroenterology/hepatology at Digestive Disease Associates in Wyomissing, Pa. The author has disclosed no potential conflicts of interest, financial or otherwise.
Abstract
Over the past decade, fatty liver disease has become a forefront health issue. The clinical implication of this silent disease extends well beyond just the liver and is linked to a variety of health concerns, including cardiovascular disease, diabetes, and cancer. The prevalence of fatty liver disease in the United States is estimated to be 25% and increasing. This article reviews the pathophysiology of fatty liver disease, how clinicians can recognize contributing factors, and appropriate interventions based on the American Association for the Study of Liver Disease's guidelines.